Acute Liver Failure Due to Etodolac, a Selective Cycloxygenase- 2 (COX -2) Inhibitor Non-Steroidal Anti-Inflammatory Drug Established by RUCAM-Based Causality Assessment
Sunil Taneja(Indraprastha Apollo Hospitals), Yogesh Chawla(University of Nebraska–Lincoln), Radha K. Dhiman(Sanjay Gandhi Post Graduate Institute of Medical Sciences), Pramod Kumar(Post Graduate Institute of Medical Education and Research), Ajay Duseja(Post Graduate Institute of Medical Education and Research), Sahaj Rathi(Post Graduate Institute of Medical Education and Research), Virendra Singh(Rayat Bahra University)
Cited by 6
Related Papers
Lactulose improves cognitive functions and health-related quality of life in patients with cirrhosis who have minimal hepatic encephalopathy
|Hepatology|2007|599
Epidemiology and Effects of Bacterial Infections in Patients With Cirrhosis Worldwide
|Gastroenterology|2018|513
Noradrenaline vs. terlipressin in the treatment of hepatorenal syndrome: A randomized study
|Journal of Hepatology|2012|269
Non‐cirrhotic portal fibrosis (idiopathic portal hypertension): Experience with 151 patients and a review of the literature
|Journal of Gastroenterology and Hepatology|2002|233
Granulocyte Colony-Stimulating Factor in Severe Alcoholic Hepatitis: A Randomized Pilot Study
|The American Journal of Gastroenterology|2014|226